NPM1 and cancer: In the past studies, most of researchers found that overexpression of NPM may promote tumors progression and predict poor prognosis of cancer patients, and they even expected NPM as a new biomolecular marker for improving clinical cancer therapy and outcomes [4, 32, 34].